TERBOWAL 250MG TABLET 7'S

The safety of TERBOWAL 250MG TABLET 7'S during pregnancy is not well established. It is generally recommended to avoid TERBOWAL 250MG TABLET 7'S use during pregnancy unless the benefits outweigh the potential risks.

TERBOWAL 250MG TABLET 7'S can be used for scalp fungal infections. It is available in both oral and topical forms, but oral administration is usually more effective for scalp infections.

TERBOWAL 250MG TABLET 7'S has the potential for drug interactions with certain medications, such as cyclosporine, cimetidine, rifampin, and some antidepressants. It's important to consult with a healthcare professional or pharmacist to check for any specific drug interactions.

Common side effects of TERBOWAL 250MG TABLET 7'S may include gastrointestinal disturbances (such as nausea, diarrhea, or stomach pain), headache, taste disturbances, and skin rashes. Serious side effects are rare but can include liver problems, blood disorders, and allergic reactions.

The duration for TERBOWAL 250MG TABLET 7'S to work depends on the type and severity of the fungal infection. In general, it may take several weeks to a few months of continuous treatment to see improvement.

Although rare, TERBOWAL 250MG TABLET 7'S has been associated with cases of liver damage. It is important to monitor liver function during TERBOWAL 250MG TABLET 7'S treatment, especially in patients with pre-existing liver conditions or a history of liver disease.

TERBOWAL 250MG TABLET 7'S can generally be used safely in elderly patients. However, caution should be exercised, and regular monitoring of liver function is recommended due to the increased risk of liver-related side effects in this population.

TERBOWAL 250MG TABLET 7'S can be used to treat fungal infections in children. However, the appropriate dosage and duration of treatment may vary based on the child's age and weight. It is best to consult a healthcare professional for proper guidance and dosage recommendations for children.